Citadel Advisors’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.5M Sell
140,400
-25,800
-16% -$5.44M ﹤0.01% 1987
2025
Q4
$33M Sell
166,200
-85,200
-34% -$17.2M 0.01% 1819
2025
Q3
$51M Buy
251,400
+93,700
+59% +$16.6M 0.01% 1358
2025
Q2
$27.8M Sell
157,700
-67,900
-30% -$10.2M ﹤0.01% 1770
2025
Q1
$30.3M Sell
225,600
-185,600
-45% -$24.4M 0.01% 1582
2024
Q4
$51.9M Sell
411,200
-337,500
-45% -$50.2M 0.01% 1237
2024
Q3
$124M Sell
748,700
-29,300
-4% -$4.43M 0.02% 574
2024
Q2
$103M Buy
778,000
+111,600
+17% +$13.4M 0.02% 672
2024
Q1
$70M Buy
666,400
+21,400
+3% +$1.92M 0.01% 961
2023
Q4
$48.7M Buy
645,000
+66,500
+11% +$4.22M 0.01% 1210
2023
Q3
$38.1M Sell
578,500
-17,700
-3% -$1.32M 0.01% 1293
2023
Q2
$48.5M Buy
596,200
+2,600
+0.4% +$185K 0.01% 1081
2023
Q1
$35.3M Sell
593,600
-64,000
-10% -$3.56M 0.01% 1384
2022
Q4
$32.1M Buy
657,600
+343,500
+109% +$15.9M 0.01% 1496
2022
Q3
$16.2M Buy
314,100
+33,900
+12% +$2.01M ﹤0.01% 2122
2022
Q2
$14.7M Sell
280,200
-30,200
-10% -$2.1M ﹤0.01% 2194
2022
Q1
$26.7M Buy
310,400
+24,900
+9% +$2.05M 0.01% 1675
2021
Q4
$23.3M Buy
285,500
+114,400
+67% +$8.36M ﹤0.01% 1851
2021
Q3
$11.4M Buy
171,100
+3,100
+2% +$220K ﹤0.01% 2846
2021
Q2
$11.3M Buy
168,000
+9,400
+6% +$583K ﹤0.01% 2902
2021
Q1
$8.25M Buy
158,600
+29,700
+23% +$1.5M ﹤0.01% 3276
2020
Q4
$5.15M Sell
128,900
-2,900
-2% -$93.6K ﹤0.01% 3629
2020
Q3
$3.23M Sell
131,800
-37,400
-22% -$956K ﹤0.01% 3861
2020
Q2
$3.06M Buy
169,200
+78,300
+86% +$1.54M ﹤0.01% 3836
2020
Q1
$1.31M Sell
90,900
-205,900
-69% -$5.91M ﹤0.01% 4852
2019
Q4
$11.3M Sell
296,800
-56,000
-16% -$1.68M ﹤0.01% 2070
2019
Q3
$7.8M Buy
352,800
+52,000
+17% +$1.11M ﹤0.01% 2526
2019
Q2
$6.21M Buy
300,800
+83,200
+38% +$1.92M ﹤0.01% 2782
2019
Q1
$6.28M Buy
217,600
+47,900
+28% +$1.18M ﹤0.01% 2671
2018
Q4
$2.91M Sell
169,700
-53,900
-24% -$1.3M ﹤0.01% 3564
2018
Q3
$6.36M Sell
223,600
-29,900
-12% -$987K ﹤0.01% 2670
2018
Q2
$8.51M Buy
253,500
+153,500
+154% +$4.77M ﹤0.01% 2125
2018
Q1
$2.42M Sell
100,000
-294,400
-75% -$5.86M ﹤0.01% 3443
2017
Q4
$5.98M Buy
394,400
+227,100
+136% +$3.2M ﹤0.01% 2267
2017
Q3
$2.75M Buy
167,300
+95,800
+134% +$1.62M ﹤0.01% 3029
2017
Q2
$1.38M Sell
71,500
-51,300
-42% -$895K ﹤0.01% 3643
2017
Q1
$2.17M Buy
122,800
+8,300
+7% +$154K ﹤0.01% 2984
2016
Q4
$1.7M Buy
114,500
+46,400
+68% +$832K ﹤0.01% 3148
2016
Q3
$1.54M Buy
68,100
+22,000
+48% +$573K ﹤0.01% 3272
2016
Q2
$1.27M Buy
46,100
+200
+0.4% +$5.91K ﹤0.01% 3274
2016
Q1
$1.33M Sell
45,900
-34,500
-43% -$898K ﹤0.01% 3131
2015
Q4
$2.44M Sell
80,400
-35,600
-31% -$1.17M ﹤0.01% 2547
2015
Q3
$4.28M Sell
116,000
-36,100
-24% -$1.87M ﹤0.01% 2103
2015
Q2
$8.8M Buy
152,100
+47,300
+45% +$2.42M 0.01% 1563
2015
Q1
$5.19M Buy
104,800
+15,000
+17% +$701K ﹤0.01% 2004
2014
Q4
$4.55M Buy
89,800
+16,400
+22% +$857K ﹤0.01% 2070
2014
Q3
$4.36M Sell
73,400
-19,200
-21% -$1.07M ﹤0.01% 2111
2014
Q2
$4.35M Buy
92,600
+44,200
+91% +$2M 0.01% 1962
2014
Q1
$2.07M Sell
48,400
-11,200
-19% -$494K ﹤0.01% 2622
2013
Q4
$2.51M Buy
59,600
+48,000
+414% +$2.09M ﹤0.01% 2328
2013
Q3
$478K Sell
11,600
-6,500
-36% -$272K ﹤0.01% 3863
2013
Q2
$834K Buy
+18,100
New +$810K ﹤0.01% 3353

Other funds holding THC

Citadel Advisors's THC Position: Q1 2026 in Review

Citadel Advisors increased its Tenet Healthcare (THC) stake by 1,088% in Q1 2026, buying an estimated $80.8M and bringing the position to 418,796 shares worth $79M. The position accounts for 0.01% of the portfolio, ranked #985.

Citadel Advisors first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $322M in Q2 2025. 690 funds tracked by Wall St. Rank hold THC as of Q1 2026.

  • Citadel Advisors held 418,796 shares of Tenet Healthcare worth $79M as of Q1 2026.
  • Citadel Advisors bought 383,553 Tenet Healthcare shares in Q1 2026, an estimated $80.8M.
  • Tenet Healthcare made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #985 holding.
  • Citadel Advisors first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Tenet Healthcare position peaked at $322M in Q2 2025.
  • 690 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.